紫杉醇
Paclitaxel;N-BENZYL-BETA-PHENYLISOSERINE ESTER;PACLITAXEL, TAXUS BREVIFOLIA;PACLITAXEL, TAXUS SPECIES;PACLITAXOL;TAXOL(TM);taxol a;TAXOL EQUIVALENT;PACLITAXEL(P);PACLITAXEL(P) PrintBack;PACLITAXEL(RG);Paclitaxel(Taxol);PACLITAXEL,Taxol;Taxol; (-)-Paclitaxel;ABI 007;Capxol;DHP 107;EMPAC;NK 105;Onxal;taxal;TAXUS;Desmocap11;7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete benzenepropanoic acid deriv.;BSPBio_002614;IDI1_000441;Spectrum5_001491;KBioGR_000492;KBio2_002016;Pharmakon1600-01503908;NCGC00024995-10;Spectrum4_001197;HMS3676G15;HMS1922K08;BRD-A28746609-001-05-7;KBio2_005628;AKOS015960460;UPCMLD-DP108:001;Bio1_000362;SDCCGMLS-0066823.P001;SR-01000597377-1;KBio3_000904;AB00172230_04;SR-01000597377;LMPR0104390001;KBio1_000441;NSC-758645;SDCCGSBI-0051168.P004;Bio2_000416;[2aR-[2a?,4?,4a?,6?,9?(?R*,?S*),11?,12?,12a?,12b?]]-?-(Benzoylamino)-?-hydroxy-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester benzenepropanoic acid;BP-23960;T 7402;HMS1792J13;SPECTRUM1503908;HMS1362J13;IDI1_002171;NCGC00024995-06;KBio3_000903;AB00172230-03;KBioSS_002016;LP01201;NCGC00024995-03;BRD-A28746609-001-04-0;SCHEMBL788187;NCGC00024995-43;NCGC00024995-05;AKOS015894977;HMS501G03;CCG-40266;KBioSS_000492;CHEMBL48;NS00003967;KBio2_003060;NCGC00024995-08;AC-675;Bio2_000896;NINDS_000441;KBioGR_001893;Paclitaxel (Taxol);NCGC00024995-13;NCGC00024995-02;KBio2_004584;HMS2093K15;HMS3412G15;AS-11004;Spectrum_001536;NSC758645;SMP1_000228;SBI-0051168.P003;BSPBio_001152;EU-0101201;s1150;NCGC00024995-07;P1632;KBio3_001834;UPCMLD-DP108:002;C07394;NCGC00024995-09;NCGC00024995-04;Lopac0_001201;SPBio_000943;BRD-A28746609-001-02-4;DivK1c_000441;KBio2_000492;Spectrum2_000872;KBio2_007152;Bio1_000851;Spectrum3_001057;Bio1_001340;AB00172230_05;Probes2_000350;HMS1990J13;Genexol-PM;PACLITAXEL [EP MONOGRAPH];ABI-007;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-4,6,12b-Tris(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (alphaR,betaS)-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate;5-BETA,20-EPOXY-1,2-ALPHA,4,7-BETA,10-BETA,13-ALPHA-HEXAHYDROXY-TAX-11-EN-9-ONE 4,10-DIACETATE 2-BENZOATE 13-ESTER WITH (2R,3S)-N-BENZOYL-3-PHENYL-ISOSERINE;OncoGel;Anzatax;BRD-K62008436-001-03-1;HMS3712O12;3PPC5TL76P;Nanotaxel;KBioGR_002509;CAS-33069-62-4;L01CD01;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro 4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano 5Hcyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate,;CHEBI:45863;Cypher select;(NAB)-Paclitaxel;AB00513812-03;ABRAXANE COMPONENT PACLITAXEL;5beta,20-Epoxy-1,2 alpha, 4,7beta, 10beta, 13alpha-hexahydroxy tax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester wi...